{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,8,17]],"date-time":"2026-08-17T14:58:48Z","timestamp":1786978728492,"version":"build-2736575974"},"publisher-location":"New York, NY","reference-count":29,"publisher":"Springer US","isbn-type":[{"value":"9781071631744","type":"print"},{"value":"9781071631751","type":"electronic"}],"license":[{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2023,1,1]],"date-time":"2023-01-01T00:00:00Z","timestamp":1672531200000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2023]]},"DOI":"10.1007\/978-1-0716-3175-1_32","type":"book-chapter","created":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T03:02:13Z","timestamp":1684465333000},"page":"487-504","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Automated and Rapid ADAMTS13 Testing Using Chemiluminescence: Utility for Identification or Exclusion of TTP and Beyond"],"prefix":"10.1007","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-2103-1661","authenticated-orcid":false,"given":"Emmanuel J.","family":"Favaloro","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kent","family":"Chapman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Soma","family":"Mohammed","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ronny","family":"Vong","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-8237-6743","authenticated-orcid":false,"given":"Leonardo","family":"Pasalic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2023,5,20]]},"reference":[{"key":"32_CR1","doi-asserted-by":"publisher","first-page":"312","DOI":"10.1111\/jth.13571","volume":"15","author":"Scully M, Cataland S, Coppo P, et al, for the International Working Group for Thrombotic Thrombocytopenic Purpura","year":"2017","unstructured":"Scully M, Cataland S, Coppo P, et al, for the International Working Group for Thrombotic Thrombocytopenic Purpura (2017) Consensus on the standardization of terminology in thrombotic thrombocytopenic purpura and related thrombotic microangiopathies. J Thromb Haemost 15:312\u2013322. https:\/\/doi.org\/10.1111\/jth.13571","journal-title":"J Thromb Haemost"},{"key":"32_CR2","doi-asserted-by":"publisher","first-page":"17020","DOI":"10.1038\/nrdp.2017.20","volume":"3","author":"JA Kremer Hovinga","year":"2017","unstructured":"Kremer Hovinga JA, Coppo P, L\u00e4mmle B, Moake JL, Miyata T, Vanhoorelbeke K (2017) Thrombotic thrombocytopenic purpura. Nat Rev Dis Primers 3:17020. https:\/\/doi.org\/10.1038\/nrdp.2017.20","journal-title":"Nat Rev Dis Primers"},{"key":"32_CR3","doi-asserted-by":"publisher","first-page":"1889","DOI":"10.1111\/jth.13764","volume":"15","author":"M Saha","year":"2017","unstructured":"Saha M, McDaniel JK, Zheng XL (2017) Thrombotic thrombocytopenic purpura: pathogenesis, diagnosis and potential novel therapeutics. J Thromb Haemost 15:1889\u20131900. https:\/\/doi.org\/10.1111\/jth.13764","journal-title":"J Thromb Haemost"},{"key":"32_CR4","doi-asserted-by":"publisher","first-page":"289","DOI":"10.1055\/s-0040-1708541","volume":"46","author":"R Blennerhassett","year":"2020","unstructured":"Blennerhassett R, Curnow J, Pasalic L (2020) Immune-mediated thrombotic thrombocytopenic purpura: a narrative review of diagnosis and treatment in adults. Semin Thromb Hemost 46:289\u2013301. https:\/\/doi.org\/10.1055\/s-0040-1708541","journal-title":"Semin Thromb Hemost"},{"key":"32_CR5","doi-asserted-by":"publisher","first-page":"323","DOI":"10.1111\/j.1365-2141.2012.09167.x","volume":"158","author":"M Scully","year":"2012","unstructured":"Scully M, Hunt BJ, Benjamin S, Liesner R, Rose P, Peyvandi F, Cheung B, Machin SJ (2012) Guidelines on the diagnosis and management of thrombotic thrombocytopenic purpura and other thrombotic microangiopathies. Br J Haematol 158:323\u2013335. https:\/\/doi.org\/10.1111\/j.1365-2141.2012.09167.x","journal-title":"Br J Haematol"},{"key":"32_CR6","doi-asserted-by":"publisher","first-page":"903","DOI":"10.1182\/blood-2018-02-791533","volume":"132","author":"C Masias","year":"2018","unstructured":"Masias C, Cataland SR (2018) The role of ADAMTS13 testing in the diagnosis and management of thrombotic microangiopathies and thrombosis. Blood 132:903\u2013910. https:\/\/doi.org\/10.1182\/blood-2018-02-791533","journal-title":"Blood"},{"key":"32_CR7","doi-asserted-by":"publisher","first-page":"400","DOI":"10.1055\/s-0041-1727282","volume":"47","author":"EJ Favaloro","year":"2021","unstructured":"Favaloro EJ, Henry BM, Lippi G (2021) Increased VWF and decreased ADAMTS13 in COVID-19: creating a milieu for (micro)thrombosis? Semin Thromb Hemost 47:400\u2013418. https:\/\/doi.org\/10.1055\/s-0041-1727282","journal-title":"Semin Thromb Hemost"},{"key":"32_CR8","doi-asserted-by":"publisher","first-page":"1049","DOI":"10.1002\/ajh.26241","volume":"96","author":"EJ Favaloro","year":"2021","unstructured":"Favaloro EJ, Pasalic L, Henry B, Lippi G (2021) Laboratory testing for ADAMTS13: utility for TTP diagnosis\/exclusion and beyond. Am J Hematol 96:1049\u20131055. https:\/\/doi.org\/10.1002\/ajh.26241","journal-title":"Am J Hematol"},{"key":"32_CR9","first-page":"55","volume":"9","author":"EJ Favaloro","year":"2021","unstructured":"Favaloro EJ, Henry BM, Lippi G (2021) VWF and ADAMTS13 in COVID-19 and beyond: a question of balance. EMJ Hematol 9:55\u201368","journal-title":"EMJ Hematol"},{"issue":"Suppl 1","key":"32_CR10","doi-asserted-by":"publisher","first-page":"129","DOI":"10.1111\/ijlh.13415","volume":"43","author":"BM Henry","year":"2021","unstructured":"Henry BM, Benoit SW, de Oliveira MHS, Lippi G, Favaloro EJ, Benoit JL (2021) ADAMTS13 activity to von Willebrand factor antigen ratio predicts acute kidney injury in patients with COVID-19: evidence of SARS-CoV-2 induced secondary thrombotic microangiopathy. Int J Lab Hematol 43(Suppl 1):129\u2013136. https:\/\/doi.org\/10.1111\/ijlh.13415","journal-title":"Int J Lab Hematol"},{"key":"32_CR11","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3390\/jcdd8090115","volume":"8","author":"B Reardon","year":"2021","unstructured":"Reardon B, Pasalic L, Favaloro EJ (2021) The intriguing relationships of von Willebrand factor, ADAMTS13 and cardiac disease. J Cardiovasc Dev Dis 8:115. https:\/\/doi.org\/10.3390\/jcdd8090115","journal-title":"J Cardiovasc Dev Dis"},{"key":"32_CR12","doi-asserted-by":"publisher","first-page":"557","DOI":"10.3390\/healthcare10030557","volume":"10","author":"CK Colonne","year":"2022","unstructured":"Colonne CK, Favaloro EJ, Pasalic L (2022) The intriguing connections between von Willebrand factor, ADAMTS13 and cancer. Healthcare (Basel) 10:557. https:\/\/doi.org\/10.3390\/healthcare10030557","journal-title":"Healthcare (Basel)"},{"key":"32_CR13","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1111\/jth.15157","volume":"19","author":"EJ Favaloro","year":"2021","unstructured":"Favaloro EJ, Mohammed S, Chapman K et al (2021) A multicentre laboratory assessment of a new automated chemiluminescent assay for ADAMTS13 activity. J Thromb Haemost 19:417\u2013428. https:\/\/doi.org\/10.1111\/jth.15157","journal-title":"J Thromb Haemost"},{"key":"32_CR14","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1055\/s-0039-1696718","volume":"19","author":"C Valsecchi","year":"2019","unstructured":"Valsecchi C, Mirabet M, Mancini I et al (2019) Evaluation of a new, rapid, fully automated assay for the measurement of ADAMTS-13 activity. Thromb Haemost 19:1767\u20131772. https:\/\/doi.org\/10.1055\/s-0039-1696718","journal-title":"Thromb Haemost"},{"key":"32_CR15","first-page":"H21","volume-title":"5th","author":"Clinical and Laboratory Standards Institute","year":"2008","unstructured":"Clinical and Laboratory Standards Institute (2008) Collection, transport, and processing of blood specimens for testing plasma-based coagulation assays and molecular hemostasis assays; approved guideline. In: Document CLSI (ed) 5th. Clinical and Laboratory Standards Institute, Wayne, PA, pp H21\u2013HA5"},{"key":"32_CR16","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1055\/s-0032-1315961","volume":"38","author":"G Lippi","year":"2012","unstructured":"Lippi G, Salvagno GL, Montagnana M, Lima-Oliveira G, Guidi GC, Favaloro EJ (2012) Quality standards for sample collection in coagulation testing. Semin Thromb Hemost 38:565\u2013575. https:\/\/doi.org\/10.1055\/s-0032-1315961","journal-title":"Semin Thromb Hemost"},{"key":"32_CR17","doi-asserted-by":"publisher","first-page":"576","DOI":"10.1055\/s-0032-1319768","volume":"38","author":"DM Adcock Funk","year":"2012","unstructured":"Adcock Funk DM, Lippi G, Favaloro EJ (2012) Quality standards for sample processing, transportation, and storage in hemostasis testing. Semin Thromb Hemost 38:576\u2013585. https:\/\/doi.org\/10.1055\/s-0032-1319768","journal-title":"Semin Thromb Hemost"},{"key":"32_CR18","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1111\/ijlh.12004","volume":"35","author":"I Mackie","year":"2013","unstructured":"Mackie I, Cooper P, Lawrie A, Kitchen S, Gray E, Laffan M, British Committee for Standards in Haematology (2013) Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis. Int J Lab Hematol 35:1\u201313. https:\/\/doi.org\/10.1111\/ijlh.12004","journal-title":"Int J Lab Hematol"},{"key":"32_CR19","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1111\/bjh.16776","volume":"191","author":"Baker P, Platton S, Gibson C, Gray E, Jennings I, Murphy P, Laffan M, British Society for Haematology, Haemostasis and Thrombosis Task Force","year":"2020","unstructured":"Baker P, Platton S, Gibson C, Gray E, Jennings I, Murphy P, Laffan M, British Society for Haematology, Haemostasis and Thrombosis Task Force (2020) Guidelines on the laboratory aspects of assays used in haemostasis and thrombosis. Br J Haematol 191:347\u2013362. https:\/\/doi.org\/10.1111\/bjh.16776","journal-title":"Br J Haematol"},{"key":"32_CR20","doi-asserted-by":"publisher","first-page":"685","DOI":"10.1111\/ijlh.13295","volume":"42","author":"I Mackie","year":"2020","unstructured":"Mackie I, Mancini I, Muia J, Kremer Hovinga J, Nair S, Machin S, Baker R (2020) International Council for Standardization in haematology (ICSH) recommendations for laboratory measurement of ADAMTS13. Int J Lab Hematol 42:685\u2013696","journal-title":"Int J Lab Hematol"},{"key":"32_CR21","doi-asserted-by":"publisher","first-page":"1151","DOI":"10.1111\/jth.12881","volume":"13","author":"AR Hubbard","year":"2015","unstructured":"Hubbard AR, Heath AB, Kremer Hovinga JA, Subcommittee on von Willebrand Factor (2015) Establishment of the WHO 1st international standard ADAMTS13, plasma (12\/252): communication from the SSC of the ISTH. J Thromb Haemost 13:1151\u20131153. https:\/\/doi.org\/10.1111\/jth.12881","journal-title":"J Thromb Haemost"},{"key":"32_CR22","volume-title":"CLSI document C28-A3c","author":"Clinical and Laboratory Standards Institute","year":"2008","unstructured":"Clinical and Laboratory Standards Institute (2008) Defining, establishing, and verifying reference intervals in the clinical laboratory; approved guideline\u2014third edition. In: CLSI document C28-A3c. Clinical and Laboratory Standards Institute, Wayne, PA"},{"key":"32_CR23","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-0716-3175-1_36","volume-title":"Hemostasis and thrombosis: methods and protocols","author":"GW Moore","year":"2023","unstructured":"Moore GW, Vetr H, Binder NB (2023) ADAMTS13 antibody and inhibitor assays. In: Favaloro EJ, Gosselin RC (eds) Hemostasis and thrombosis: methods and protocols. Methods in molecular biology. Springer, New York, pp 549\u2013565. https:\/\/doi.org\/10.1007\/978-1-0716-3175-1_36"},{"key":"32_CR24","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-0716-3175-1_33","volume-title":"Hemostasis and thrombosis: methods and protocols","author":"EJ Favaloro","year":"2023","unstructured":"Favaloro EJ, Chapman K, Mohammed S, Vong R, Pasalic L (2023) Identification of ADAMTS13 inhibitors in acquired TTP. In: Favaloro EJ, Gosselin RC (eds) Hemostasis and thrombosis: methods and protocols. Methods in molecular biology. Springer, New York, pp 505\u2013521. https:\/\/doi.org\/10.1007\/978-1-0716-3175-1_33"},{"key":"32_CR25","doi-asserted-by":"publisher","DOI":"10.1007\/978-1-0716-3175-1_43","volume-title":"Hemostasis and thrombosis: methods and protocols","author":"EJ Favaloro","year":"2023","unstructured":"Favaloro EJ, Mohammed S, Vong R, Pasalic L (2023) Laboratory testing for von Willebrand disease using a composite rapid 3-test chemiluminescence-based von Willebrand factor assay panel. In: Favaloro EJ, Gosselin RC (eds) Hemostasis and thrombosis: methods and protocols. Methods in molecular biology. Springer, New York, pp 647\u2013667. https:\/\/doi.org\/10.1007\/978-1-0716-3175-1_43"},{"key":"32_CR26","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/978-1-4939-7196-1_30","volume":"1646","author":"EJ Favaloro","year":"2017","unstructured":"Favaloro EJ, Mohammed S, Patzke J (2017) Laboratory testing for von Willebrand factor antigen (VWF:Ag). Methods Mol Biol 1646:403\u2013416. https:\/\/doi.org\/10.1007\/978-1-4939-7196-1_30","journal-title":"Methods Mol Biol"},{"key":"32_CR27","doi-asserted-by":"publisher","first-page":"417","DOI":"10.1007\/978-1-4939-7196-1_31","volume":"1646","author":"EJ Favaloro","year":"2017","unstructured":"Favaloro EJ, Mohammed S (2017) Laboratory testing for von Willebrand factor collagen binding (VWF:CB). Methods Mol Biol 1646:417\u2013433. https:\/\/doi.org\/10.1007\/978-1-4939-7196-1_31","journal-title":"Methods Mol Biol"},{"key":"32_CR28","doi-asserted-by":"publisher","first-page":"435","DOI":"10.1007\/978-1-4939-7196-1_32","volume":"1646","author":"S Mohammed","year":"2017","unstructured":"Mohammed S, Favaloro EJ (2017) Laboratory testing for von Willebrand factor ristocetin cofactor (VWF:RCo). Methods Mol Biol 1646:435\u2013451. https:\/\/doi.org\/10.1007\/978-1-4939-7196-1_32","journal-title":"Methods Mol Biol"},{"key":"32_CR29","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1007\/978-1-4939-7196-1_33","volume":"1646","author":"J Patzke","year":"2017","unstructured":"Patzke J, Favaloro EJ (2017) Laboratory testing for von Willebrand factor activity by glycoprotein Ib binding assays (VWF:GPIb). Methods Mol Biol 1646:453\u2013460. https:\/\/doi.org\/10.1007\/978-1-4939-7196-1_33","journal-title":"Methods Mol Biol"}],"container-title":["Methods in Molecular Biology","Hemostasis and Thrombosis"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/978-1-0716-3175-1_32","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,5,19]],"date-time":"2023-05-19T03:06:40Z","timestamp":1684465600000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/978-1-0716-3175-1_32"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2023]]},"ISBN":["9781071631744","9781071631751"],"references-count":29,"URL":"https:\/\/doi.org\/10.1007\/978-1-0716-3175-1_32","relation":{},"ISSN":["1064-3745","1940-6029"],"issn-type":[{"value":"1064-3745","type":"print"},{"value":"1940-6029","type":"electronic"}],"subject":[],"published":{"date-parts":[[2023]]},"assertion":[{"value":"20 May 2023","order":1,"name":"first_online","label":"First Online","group":{"name":"ChapterHistory","label":"Chapter History"}}]}}